Literature DB >> 8693940

Uterine leiomyosarcoma in patient receiving tamoxifen therapy.

W G McCluggage1, M Varma, P Weir, H Bharucha.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8693940     DOI： 10.3109/00016349609054678

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN： 0001-6349            Impact factor:   3.636


× No keyword cloud information.
  4 in total

1.  Effects of hormonally active agents on steroid hormone receptor expression and cell proliferation in the myometrium of ovariectomized macaques.

Authors:  Georgette D Hill; Alicia B Moore; Grace E Kissling; Norris D Flagler; Elizabeth Ney; J Mark Cline; Darlene Dixon
Journal:  Toxicol Pathol       Date:  2011-03-16       Impact factor: 1.902

Review 2.  Uterine myxoid leiomyosarcoma - a rare malignant tumor: the role of complex morphopathological assay. Review and case presentation.

Authors:  Anca Maria Istrate-Ofiţeru; George Lucian Zorilă; Dan Ruican; Ana Maria Petrescu; Elena Iuliana Anamaria Berbecaru; Gabriela Camelia Roşu; Răzvan Grigoraş Căpitănescu; Rodica Daniela Nagy; Liliana Cercelaru; Antonie Edu; Dominic Gabriel Iliescu; Roxana Cristina Drăguşin
Journal:  Rom J Morphol Embryol       Date:  2021 Oct-Dec       Impact factor: 0.833

Review 3.  Etiology and pathogenesis of uterine leiomyomas: a review.

Authors:  Gordon P Flake; Janet Andersen; Darlene Dixon
Journal:  Environ Health Perspect       Date:  2003-06       Impact factor: 9.031

Review 4.  Interrogating the Genomic Landscape of Uterine Leiomyosarcoma: A Potential for Patient Benefit.

Authors:  Genevieve V Dall; Anne Hamilton; Gayanie Ratnayake; Clare Scott; Holly Barker
Journal:  Cancers (Basel)       Date:  2022-03-18       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.